SUMMARY A fatal case of neonatal cytomegalovirus (CMV) infection attributed to exchange transfusion is described. The incidence of CMV transmission by exchange and other neonatal transfusion was studied, and the use of CMV antibody-free blood for these procedures was shown to be effective in preventing CMV infection in neonates.
prospectively. The retrospective group were seen at least once between ages 10 weeks and 14 months, at which time the babies were physically examined and their development, head circumferences, and hearing were assessed. Blood for CMV complementfixation tests and immunofluorescent antibody (de Silva et al., 1977) was taken from both mother and baby, and a throat swab and urine were taken from the baby for virus isolation on human embryo fibroblast cultures. In the prospective group blood was taken from the mother within 2 weeks after transfusion of the baby, and a throat swab and urine were collected from the baby for virus culture within 3 days of transfusion. The mothers and babies in this group were seen again between 3 and 6 months after transfusion, and 8 of them were seen a second time at between 6 and 9 months; at these times the baby was clinically assessed and a throat swab, urine, and blood were taken for virus investigation as in the retrospective group.
All the 42 babies studied retrospectively received blood from donors who had not been screened for CMV antibody, although subsequently the CMV antibody titres of all blood donors were determined for 33 of the babies. For the remaining 9 babies the CMV titre of at least one donor could not be ascertained. In the prospective group of 22 babies one or more donors for 3 babies were not available for CMV serological tests. 16 babies were given CMV antibody-free blood deliberately.
97 infants aged between 5 and 18 months, who had not been transfused and who were attending an infant welfare clinic, or were in hospital, served as controls; they were tested for CMV infection either by virus isolation or serology.
Results
In the first 13 months of the study, before a policy of selection of CMV-negative donors was introduced, 538 Exchange transfusions. The 4 babies who became infected after exchange transfusions received on average 864 ml blood from 4 donors for each baby, compared with an average of 480 ml from 2 donors for those 14 uninfected. Three of the 4 babies infected after exchange transfusion showed no clinical signs attributable to CMV during the period of observation. The 4th, who subsequently died, is described below.
Case report
A 33-year-old group 0 Rhesus-negative mother who had previously had 3 liveborn babies and one stillborn baby affected by rhesus iso-immunisation, Maternal CMV infection. Sera from 6 of the 8 mothers of infected babies were available for testing from late pregnancy and again when the babies were seen for follow-up. Five of these mothers had antibody to CMV before delivery, 4 of whom showed no change in titre. One showed a 16-fold rise in complement-fixation titre from 1: 8 to 1:96 at 8 months after delivery, indicating reinfection or reactivation of her previous CMV infection. The 6th mother who had no CMV antibody before delivery showed a raised titre (1:32) when tested 5 months postpartum.
Discussion
Although cytomegalovirus infection after blood transfusions usually produces no clinical disease, in a few patients it can produce post-transfusion mononucleosis (Foster and Jack, 1969) , and this syndrome can occur at any age including the first few weeks of life (Tobin et al., 1975 
